Dual function of eosinophils in pathogenesis and protective immunity against parasites

Dual function of eosinophils in pathogenesis and protective immunity against parasites

The functional duality of eosinophils, involved in a protective response or in pathogenesis is illustrated in various parasitic infections. In schistosomiasis, eosinophils have been shown to mediate schistosomula killing, in the presence of antibodies. The association of eosinophil-dependent cytotox...

Full description

Bibliographic Details
Main Author:	Monique Capron
Format:	Article
Language:	English
Published:	Fundação Oswaldo Cruz (FIOCRUZ) 1992-01-01
Series:	Memorias do Instituto Oswaldo Cruz
Subjects:	eosinophils schistosomiasis protection cytotoxicity IL-5
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761992000900012

Similar Items

Effector functions of eosinophils in schistosomiasis
by: Monique Capron, et al.
Published: (1992-01-01)

Clinical Significance of Interleukin 33 (IL-33) in Patients with Eosinophilic Pneumonia
by: Naoko Mato, et al.
Published: (2013-01-01)

Role of biologics in severe eosinophilic asthma – focus on reslizumab
by: Pelaia G, et al.
Published: (2016-07-01)

MONOCLONAL ANTIBODY-BASED THERAPY FOR EOSINOPHILIC OESOPHAGITIS
by: Garry Walsh
Published: (2016-12-01)

A case of paradoxical eosinophilic fasciitis in a patient on benralizumab
by: Michael J. Woodbury, BS, et al.
Published: (2023-10-01)

Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma
by: Haldar P
Published: (2017-06-01)

The Biology of Eosinophils and Their Role in Asthma
by: Claire N. McBrien, et al.
Published: (2017-06-01)

Expression of eosinophil β chain-signaling cytokines receptors, outer-membrane integrins, and type 2 inflammation biomarkers in severe non-allergic eosinophilic asthma
by: Virginija Kalinauskaite-Zukauske, et al.
Published: (2019-08-01)

Bone marrow contribution to eosinophilic inflammation
by: Denburg Judah A, et al.
Published: (1997-01-01)

Eosinophils Play a Surprising Leading Role in Recurrent Urticaria in Horses
by: Katharina Birkmann, et al.
Published: (2024-05-01)

Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab
by: Pelaia C, et al.
Published: (2017-10-01)

Interleukin-5, Interleukin-6 and Eosinophils in COVID-19 Egyptian Patients: Potential Clues for Prognosis and Immunotherapy
by: Sara Taha, et al.
Published: (2022-01-01)

Seric chemokines and chemokine receptors in eosinophils during acute human schistosomiasis mansoni
by: Denise Silveira-Lemos, et al.
Published: (2010-07-01)

IL-5 and IL-6 are increased in the frontal recess of eosinophilic chronic rhinosinusitis patients
by: Kazunori Kubota, et al.
Published: (2017-05-01)

High expression of co-stimulatory and adhesion molecules are observed on eosinophils during human Schistosoma mansoni infection
by: Denise Silveira-Lemos, et al.
Published: (2006-10-01)

Does Eosinophil Heterogeneity Translate into Functional Diversity? A Review of the Evolving Paradigm of Eosinophil Heterogeneity in Asthma
by: Gabriella E. Wilson, et al.
Published: (2024-09-01)

Eosinophils Control Liver Damage by Modulating Immune Responses Against Fasciola hepatica
by: Sofía Frigerio, et al.
Published: (2020-09-01)

Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?
by: Andrea Matucci, et al.
Published: (2018-06-01)

The enigmatic eosinophil: investigation of the biological role of eosinophils in parasitic helmint infection
by: Karen S Ovington, et al.
Published: (1997-12-01)

Mepolizumab Therapy for Recalcitrant Eosinophilic Annular Erythema in an Adult: A Case Report and Review of Treatment Options
by: Magdalena Żychowska, et al.
Published: (2020-06-01)

Pin1 Regulates IL-5 Induced Eosinophil Polarization and Migration
by: Zhong-Jian Shen, et al.
Published: (2021-01-01)

IL-5 and GM-CSF, but Not IL-3, Promote the Proliferative Properties of Inflammatory-like and Lung Resident-like Eosinophils in the Blood of Asthma Patients
by: Jolita Palacionyte, et al.
Published: (2022-11-01)

Engineering of Humanized Antibodies Against Human Interleukin 5 Receptor Alpha Subunit That Cause Potent Antibody-Dependent Cell-Mediated Cytotoxicity
by: Jung-Eun Kim, et al.
Published: (2021-01-01)

Susceptibility to L. sigmodontis infection is highest in animals lacking IL-4R/IL-5 compared to single knockouts of IL-4R, IL-5 or eosinophils
by: Stefan J. Frohberger, et al.
Published: (2019-05-01)

The Role of Eosinophil-Derived Neurotoxin and Vascular Endothelial Growth Factor in the Pathogenesis of Eosinophilic Asthma
by: Maciej Tota, et al.
Published: (2023-05-01)

Successful treatment of eosinophilic chronic rhinosinusitis and eosinophilic otitis media using the anti-IL-5 receptor monoclonal antibody benralizumab: A case report
by: Hiroki Kagoshima, et al.
Published: (2020-01-01)

Preclinical development of a long-acting trivalent bispecific nanobody targeting IL-5 for the treatment of eosinophilic asthma
by: Linlin Ma, et al.
Published: (2022-11-01)

Evaluation Role of IL-13 and Eosinophils in Adult Asthmatic Patients
by: Meraim A. Kazaal, et al.
Published: (2023-06-01)

Bronchial asthma and interleukin-5
by: Das Undurti, et al.
Published: (2001-02-01)

Monocentric study of IL-5 monoclonal antibody induction therapy for eosinophilic granulomatosis with polyangiitis
by: Chrong-Reen Wang, et al.
Published: (2024-07-01)

How Can Dupilumab Cause Eosinophilic Pneumonia?
by: Momoko Kurihara, et al.
Published: (2022-11-01)

Schistosomiasis Mansoni-Recruited Eosinophils: An Overview in the Granuloma Context
by: Kássia K. Malta, et al.
Published: (2022-10-01)

Group 2 Innate Lymphoid Cells Protect Mice from Abdominal Aortic Aneurysm Formation via IL5 and Eosinophils
by: Yuanyuan Zhang, et al.
Published: (2023-03-01)

Vaccine strategies against schistosomiasis
by: A. Capron, et al.
Published: (1992-01-01)

Vaccination with antioxidant enzymes confers protective immunity against challenge infection with Schistosoma mansoni
by: Philip T LoVerde, et al.
Published: (2004-08-01)

Response to case report: Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
by: I. J. Pouliquen, et al.
Published: (2017-11-01)

Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center
by: Paolo Solidoro, et al.
Published: (2022-01-01)

The Role of Eosinophils in Liver DiseaseSummary
by: Linxi Xie, et al.
Published: (2025-01-01)

From allergy to schistosomes: role of Fc receptors and adhesion molecules in eosinophil effector function
by: Sophie Nutten, et al.
Published: (1997-12-01)

Rapid onset of effect of benralizumab on respiratory symptoms in a patient with eosinophilic granulomatosis with polyangiitis
by: Angelo Coppola, et al.
Published: (2020-01-01)